FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039139761> ?p ?o ?g. }

• W3039139761 endingPage "236" @default.
• W3039139761 startingPage "225" @default.
• W3039139761 abstract "As the use of Integrase inhibitor (INSTI)-class antiretroviral medications becomes more common to maintain long-term viral suppression, early reports suggest the potential for CNS side-effects when starting or switching to an INSTI-based regimen. In a population already at higher risk for developing mood and anxiety disorders, these drugs may have significant effects on PTSD scale symptom scores, particularly in women with HIV (WWH). A total of 551 participants were included after completing ≥ 1 WIHS study visits before and after starting/switching to an INSTI-based ART regimen. Of these, 14% were ART naïve, the remainder switched from primarily a protease inhibitor (PI) or non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen. Using multivariable linear mixed effects models, we compared PTSD Civilian Checklist subscale scores before and after a start/switch to dolutegravir (DTG), raltegravir (RAL), or elvitegravir (EVG). Start/switch to EVG improved re-experiencing subscale symptoms (P's < 0.05). Switching to EVG improved symptoms of avoidance (P = 0.01). Starting RAL improved arousal subscale symptoms (P = 0.03); however, switching to RAL worsened re-experiencing subscale symptoms (P < 0.005). Starting DTG worsened avoidance subscale symptoms (P = 0.03), whereas switching to DTG did not change subscale or overall PTSD symptoms (P's > 0.08). In WWH, an EVG-based ART regimen is associated with improved PTSD symptoms, in both treatment naïve patients and those switching from other ART. While a RAL-based regimen was associated with better PTSD symptoms than in treatment naïve patients, switching onto a RAL-based regimen was associated with worse PTSD symptoms. DTG-based regimens either did not affect, or worsened symptoms, in both naïve and switch patients. Further studies are needed to determine mechanisms underlying differential effects of EVG, RAL and DTG on stress symptoms in WWH." @default.
• W3039139761 created "2020-07-10" @default.
• W3039139761 creator A5006099297 @default.
• W3039139761 creator A5008434862 @default.
• W3039139761 creator A5009632243 @default.
• W3039139761 creator A5020145667 @default.
• W3039139761 creator A5023506438 @default.
• W3039139761 creator A5027919957 @default.
• W3039139761 creator A5030900258 @default.
• W3039139761 creator A5033035155 @default.
• W3039139761 creator A5038417176 @default.
• W3039139761 creator A5046497882 @default.
• W3039139761 creator A5049374899 @default.
• W3039139761 creator A5050888707 @default.
• W3039139761 creator A5056403325 @default.
• W3039139761 creator A5056825063 @default.
• W3039139761 creator A5060344154 @default.
• W3039139761 creator A5068211949 @default.
• W3039139761 creator A5068995252 @default.
• W3039139761 creator A5073377862 @default.
• W3039139761 creator A5084232309 @default.
• W3039139761 creator A5088173747 @default.
• W3039139761 date "2020-07-07" @default.
• W3039139761 modified "2023-10-15" @default.
• W3039139761 title "Starting or Switching to an Integrase Inhibitor-Based Regimen Affects PTSD Symptoms in Women with HIV" @default.
• W3039139761 cites W1602572527 @default.
• W3039139761 cites W1763274674 @default.
• W3039139761 cites W1783991670 @default.
• W3039139761 cites W1836530205 @default.
• W3039139761 cites W1969083940 @default.
• W3039139761 cites W1979053558 @default.
• W3039139761 cites W1984959581 @default.
• W3039139761 cites W2007698475 @default.
• W3039139761 cites W2011912864 @default.
• W3039139761 cites W2020566551 @default.
• W3039139761 cites W2022619519 @default.
• W3039139761 cites W2025595693 @default.
• W3039139761 cites W2031656836 @default.
• W3039139761 cites W2041080087 @default.
• W3039139761 cites W2042867111 @default.
• W3039139761 cites W2047577118 @default.
• W3039139761 cites W2050889951 @default.
• W3039139761 cites W2057510184 @default.
• W3039139761 cites W2063329141 @default.
• W3039139761 cites W2068544586 @default.
• W3039139761 cites W2077017047 @default.
• W3039139761 cites W2089992542 @default.
• W3039139761 cites W2092481091 @default.
• W3039139761 cites W2102370796 @default.
• W3039139761 cites W2106737113 @default.
• W3039139761 cites W2108939637 @default.
• W3039139761 cites W2111296179 @default.
• W3039139761 cites W2114790698 @default.
• W3039139761 cites W2120355150 @default.
• W3039139761 cites W2128955923 @default.
• W3039139761 cites W2134136254 @default.
• W3039139761 cites W2135276646 @default.
• W3039139761 cites W2146089461 @default.
• W3039139761 cites W2148535109 @default.
• W3039139761 cites W2152505869 @default.
• W3039139761 cites W2156603674 @default.
• W3039139761 cites W2157830547 @default.
• W3039139761 cites W2158934536 @default.
• W3039139761 cites W2168643019 @default.
• W3039139761 cites W2238552371 @default.
• W3039139761 cites W2327107093 @default.
• W3039139761 cites W2328173808 @default.
• W3039139761 cites W2335645007 @default.
• W3039139761 cites W2338833767 @default.
• W3039139761 cites W2340182575 @default.
• W3039139761 cites W2419567785 @default.
• W3039139761 cites W2468186002 @default.
• W3039139761 cites W2539540085 @default.
• W3039139761 cites W2554692247 @default.
• W3039139761 cites W2556153964 @default.
• W3039139761 cites W2562322368 @default.
• W3039139761 cites W2563325297 @default.
• W3039139761 cites W2586218254 @default.
• W3039139761 cites W2600344958 @default.
• W3039139761 cites W2608989554 @default.
• W3039139761 cites W2728117782 @default.
• W3039139761 cites W2741165009 @default.
• W3039139761 cites W2754107698 @default.
• W3039139761 cites W2766073162 @default.
• W3039139761 cites W2789803651 @default.
• W3039139761 cites W2791543552 @default.
• W3039139761 cites W2808490642 @default.
• W3039139761 cites W2924743347 @default.
• W3039139761 cites W2930145005 @default.
• W3039139761 cites W2938352630 @default.
• W3039139761 cites W2951224640 @default.
• W3039139761 cites W2967602084 @default.
• W3039139761 cites W4247665917 @default.
• W3039139761 cites W72358836 @default.
• W3039139761 doi "https://doi.org/10.1007/s10461-020-02967-2" @default.
• W3039139761 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7948485" @default.
• W3039139761 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32638219" @default.
• W3039139761 hasPublicationYear "2020" @default.

• next